IMPACT SCORE JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOG LaTeX 5G Tutorial Free Tools

Search About Journals, Conferences, and Book Series

Molecular Diagnosis and Therapy

Impact, Factor and Metrics, Impact Score, Ranking, h-index, SJR, Rating, Publisher, ISSN, and More

Last Updated on September 3, 2024

Impact Score

2023-2024

4.28

h-Index

2023-2024

 68

Rank

2023-2024

 3237

SJR

2023-2024

 1.214

Note: The impact score or impact index shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics and Factor

Title Molecular Diagnosis and Therapy
Abbreviation Mol. Diagn. Ther.
Publication Type Journal
Subject Area, Categories, Scope Genetics (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1); Molecular Medicine (Q2)
h-index 68
Overall Rank/Ranking 3237
SCImago Journal Rank (SJR) 1.214
Impact Score 4.28
Publisher Adis International Ltd
Country United Kingdom
ISSN 11771062
Best Quartile Q1
Coverage History 2000-2001, 2004-2023




About Molecular Diagnosis and Therapy


Molecular Diagnosis and Therapy is a journal covering the technologies/fields/categories related to Genetics (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1); Molecular Medicine (Q2). It is published by Adis International Ltd. The overall rank of Molecular Diagnosis and Therapy is 3237. According to SCImago Journal Rank (SJR), this journal is ranked 1.214. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 68. The best quartile for this journal is Q1.

The ISSN of Molecular Diagnosis and Therapy journal is 11771062. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Molecular Diagnosis and Therapy is cited by a total of 719 articles during the last 3 years (Preceding 2023).


Molecular Diagnosis and Therapy Impact IF 2023-2024


The Impact IF 2023 of Molecular Diagnosis and Therapy is 4.28, which is computed in 2024 as per its definition. Molecular Diagnosis and Therapy IF is increased by a factor of 0.37 and approximate percentage change is 9.46% when compared to preceding year 2022, which shows a rising trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Molecular Diagnosis and Therapy Impact IF 2024 Prediction


Impact IF 2023 of Molecular Diagnosis and Therapy is 4.28. If the same upward trend persists, Impact IF may rise in 2024 as well.


Impact IF Trend


Year wise Impact IF of Molecular Diagnosis and Therapy. Based on Scopus data.


Year Impact IF
2023/2024 Coming Soon
2023 4.28
2022 3.91
2021 4.29
2020 3.65
2019 3.18
2018 3.16
2017 2.70
2016 2.07
2015 2.84
2014 3.11

Molecular Diagnosis and Therapy h-index


  Table Setting

Molecular Diagnosis and Therapy has an h-index of 68. It means 68 articles of this journal have more than 68 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




Molecular Diagnosis and Therapy ISSN


The ISSN of Molecular Diagnosis and Therapy is 11771062. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

Molecular Diagnosis and Therapy Rank and SCImago Journal Rank (SJR)


The overall rank of Molecular Diagnosis and Therapy is 3237. According to SCImago Journal Rank (SJR), this journal is ranked 1.214. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.

SJR of Molecular Diagnosis and Therapy by Year


Year SJR
2023/2024 Coming Soon
2023 1.214
2022 1.030
2021 1.009
2020 1.322
2019 0.921
2018 1.069
2017 0.923
2016 0.806
2015 0.948
2014 0.977

Ranking of Molecular Diagnosis and Therapy by Year


Year Ranking
2023/2024 Coming Soon
2023 3237
2022 4026
2021 4052
2020 2799
2019 4881
2018 3944
2017 4880
2016 5801
2015 4786
2014 4490

Molecular Diagnosis and Therapy Publisher


Table Setting

Molecular Diagnosis and Therapy is published by Adis International Ltd. It's publishing house is located in United Kingdom. Coverage history of this journal is as following: 2000-2001, 2004-2023. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of Molecular Diagnosis and Therapy is Mol. Diagn. Ther.. This abbreviation ('Mol. Diagn. Ther.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in Molecular Diagnosis and Therapy


If your research field is/are related to Genetics (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1); Molecular Medicine (Q2), then please visit the official website of this journal.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.



Frequently Asked Questions (FAQs)


What's the latest impact IF of the Molecular Diagnosis and Therapy?

Molecular Diagnosis and Therapy latest impact IF is 4.28. It's evaluated in the year 2023. The highest and the lowest impact IF or impact score of this journal are 4.29 (2021) and 2.07 (2016), respectively, in the last 10 years. Moreover, its average IS is 3.32 in the previous 10 years.


What's the SCImago Journal Rank (SJR) of the Molecular Diagnosis and Therapy?

The Molecular Diagnosis and Therapy has an SJR (SCImago Journal Rank) of 1.214, according to the latest data. It is computed in the year 2024. In the past 10 years, this journal has recorded a range of SJR, with the highest being 1.322 in 2020 and the lowest being 0.806 in 2016. Furthermore, the average SJR of the Molecular Diagnosis and Therapy over the previous 10-year period stands at 3.32.


What's the latest h-index of the Molecular Diagnosis and Therapy?

The latest h-index of the Molecular Diagnosis and Therapy is 68.


Who's the publisher of the Molecular Diagnosis and Therapy?

The Molecular Diagnosis and Therapy is published by the Adis International Ltd, with its country of publication being the United Kingdom.


What's the current ranking of the Molecular Diagnosis and Therapy?

The Molecular Diagnosis and Therapy is currently ranked 3237 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 10 years, this journal has experienced varying rankings, reaching its highest position of 2799 in 2020 and its lowest position of 5801 in 2016.


What's the abbreviation or short name for the Molecular Diagnosis and Therapy?

The standard ISO4 abbreviation for the Molecular Diagnosis and Therapy is Mol. Diagn. Ther..


Is the "Molecular Diagnosis and Therapy" classified as a Journal, Conference and Proceedings, Trade Journal or Book Series?

Molecular Diagnosis and Therapy is classified as a journal that the Adis International Ltd publishes.


What's the scope or major areas of the Molecular Diagnosis and Therapy?

The Molecular Diagnosis and Therapy encompasses the following areas:

  • Genetics
  • Medicine (miscellaneous)
  • Pharmacology
  • Molecular Medicine

For a more comprehensive understanding of its scope, check the official website of this journal.


What's the ISSN of the Molecular Diagnosis and Therapy?

The Molecular Diagnosis and Therapy is assigned the following International Standard Serial Numbers (ISSN): 11771062.


What's the best quartile of the Molecular Diagnosis and Therapy?

The best quartile for the Molecular Diagnosis and Therapy is Q1 (2023).


What's the coverage history of the Molecular Diagnosis and Therapy?

The Molecular Diagnosis and Therapy coverage history can be summarized as follows: 2000-2001, 2004-2023.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Score, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
Historia journal 28724 Universidade Estadual Paulista 8 0.02
International Journal of Mathematical Education in Science and Technology journal 8417 Taylor and Francis Ltd. 42 1.17
Air and Space Power Journal (discontinued) journal 28397 AU Press 9 0.20
European Surgery - Acta Chirurgica Austriaca journal 18870 Springer Medizin 24 0.60
Exploration Geophysics journal 13768 Taylor and Francis Ltd. 50 1.06
Archives of the Balkan Medical Union journal 23592 Balkan Medical Union 12 0.21
Asian Textile Journal trade journal 27997 G P S Kwatra 11 0.03
European Journal of Wildlife Research journal 9693 Springer Verlag 59 1.76
Expert Review of Clinical Pharmacology journal 4520 Taylor and Francis Ltd. 60 3.53
Journal of Evolutionary Psychology journal 28897 Akademiai Kiado 0 0.00

Check complete list




Year wise Impact Score (IS) of Molecular Diagnosis and Therapy

Impact Score Table

Year Impact Score (IS)
2024/2025 Coming Soon
2023 4.28
2022 3.91
2021 4.29
2020 3.65
2019 3.18
2018 3.16
2017 2.70
2016 2.07
2015 2.84
2014 3.11



Top Journals/Conferences in Genetics

Cell
Elsevier B.V. | United States

Nature Medicine
Nature Research | United Kingdom

Nature Genetics
Nature Publishing Group | United Kingdom

Nature Reviews Genetics
Nature Publishing Group | United Kingdom

Nature Reviews Methods Primers
Springer Nature | United States

Cell Stem Cell
Cell Press | United States

Cell Genomics
Cell Press | United States

Signal Transduction and Targeted Therapy
Springer Nature | United Kingdom

Nature Microbiology
Nature Publishing Group | United Kingdom

Nature Protocols
Nature Publishing Group | United Kingdom

See All

Top Journals/Conferences in Medicine (miscellaneous)

Nature Reviews Drug Discovery
Nature Publishing Group | United Kingdom

New England Journal of Medicine
Massachussetts Medical Society | United States

Nature Medicine
Nature Research | United Kingdom

Current Protocols in Bioinformatics
John Wiley & Sons Inc. | United States

MMWR supplements
Epidemiology Program Office | United States

Nature Reviews Immunology
Nature Publishing Group | United Kingdom

MMWR Recommendations and Reports
Centers for Disease Control and Prevention (CDC) | United States

Annals of Oncology
Elsevier Ltd | United Kingdom

Morbidity and Mortality Weekly Report
Department of Health and Human Services | United States

Nature Reviews Methods Primers
Springer Nature | United States

See All

Top Journals/Conferences in Pharmacology

Nature Reviews Drug Discovery
Nature Publishing Group | United Kingdom

Pharmacological Reviews
American Society for Pharmacology and Experimental Therapeutics | United States

Drug Resistance Updates
Churchill Livingstone | United States

Annual Review of Pharmacology and Toxicology
Annual Reviews Inc. | United States

Molecular Therapy
Cell Press | United States

Journal for ImmunoTherapy of Cancer
BMJ Publishing Group | United Kingdom

Trends in Pharmacological Sciences
Elsevier Ltd | United Kingdom

Pharmacology and Therapeutics
Elsevier Inc. | United States

Acta Pharmaceutica Sinica B
Chinese Academy of Medical Sciences | China

Theranostics
Ivyspring International Publisher | Australia

See All

Top Journals/Conferences in Molecular Medicine

Nature Biotechnology
Nature Publishing Group | United Kingdom

Cell Stem Cell
Cell Press | United States

Molecular Cancer
BioMed Central Ltd | United Kingdom

Pharmacological Reviews
American Society for Pharmacology and Experimental Therapeutics | United States

Genome Medicine
BioMed Central Ltd | United Kingdom

EMBO Molecular Medicine
Springer | United Kingdom

Molecular Therapy
Cell Press | United States

Journal for ImmunoTherapy of Cancer
BMJ Publishing Group | United Kingdom

Experimental and Molecular Medicine
Korean Society of Med. Biochemistry and Mol. Biology | South Korea

Trends in Molecular Medicine
Elsevier Ltd | United Kingdom

See All